Clinical Trials Logo

Stage IV Gallbladder Cancer clinical trials

View clinical trials related to Stage IV Gallbladder Cancer.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02333188 Completed - Clinical trials for Pancreatic Adenocarcinoma

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Start date: December 2014
Phase: Phase 1
Study type: Interventional

This phase I/II trial studies the side effects of genetic analysis-guided dosing of paclitaxel albumin-stabilized nanoparticle formulation, fluorouracil, leucovorin calcium, and irinotecan hydrochloride (FOLFIRABRAX) in treating patients with gastrointestinal cancer that has spread to other parts of the body and usually cannot be cured or controlled with treatment. Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, fluorouracil, leucovorin calcium, and irinotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Genetic analysis may help doctors determine what dose of irinotecan hydrochloride patients can tolerate.

NCT ID: NCT01425879 Completed - Clinical trials for Advanced Adult Hepatocellular Carcinoma

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

Start date: April 2011
Phase: Phase 2
Study type: Interventional

This phase II trial is studying how well MD2206 works in treating patients with advanced refractory biliary cancer that cannot be removed by surgery.